This study presents valuable findings by reanalyzing previously published MEG and ECoG datasets to challenge the predictive nature of pre-onset neural encoding effects. The evidence supporting the ...

This study highlights the potential for using deep learning methods on longitudinal health data from both primary and ...

Complete MetLife Inc. 5.625% Non-Cum. Perp. Pfd. Series E stock information by Barron's. View real-time MET.PRE stock price and news, along with industry-best analysis.

VectorCertain LLC today announced new validation results demonstrating that its SecureAgent platform successfully detected ...